Haptoglobin in Medical Technology
Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
... enzyme immunoassay can
determine a person's
haptoglobin pheno/genotype in less than two hours, and
can ... antibody that differentiates
between the three
haptoglobin pheno/genotypes. Blood samples from diabetic
patients with known
haptoglobin pheno/genotypes were tested using
Synvista's ...
Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
... Company to Continue Focus on Pipeline and
haptoglobin Diagnostic Assay
MONTVALE, N.J., June 6 ... 2 diabetic patients. Trial 201a
established that
haptoglobin (Hp) types, the target of Synvista's
proprietary
haptoglobin variant test currently under ...
Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
... Results of Mouse Model of Diabetes with
haptoglobin 2-2 Genotype Show
Modification of HDL Structure ... data from a study of diabetic mice
with the
haptoglobin 2-2 genotype that show impairment in the clearance of
the
haptoglobin (Hp)-Hemoglobin (Hb) complex may result in a ...
Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
... patients with Diabetes Mellitus (DM) who
had the
haptoglobin 2-2 (Hp2-2) phenotype met its pre-specified, ... study, more than 3,000 patients were
tested for
haptoglobin phenotype, and 984 of these who had the ... based on cardiovascular risk
assessment, using
haptoglobin characterization, to identify patients at
high ...
Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
... SYI ) announced results from a study demonstrating the important
role of
haptoglobin (Hp) typing in determining the risk of cardiovascular
complications in ... a clinical diagnostic test, based on cardiovascular risk
assessment, using
haptoglobin characterization, to identify patients at
high risk for cardiovascular ...
Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
... development platform,
including our work developing a diagnostic test for
haptoglobin type, to
determine cardiovascular risk and a therapeutic product to ... a clinical diagnostic test, based on cardiovascular risk
assessment, using
haptoglobin characterization, to identify patients at
high risk for cardiovascular ...
Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis
... cardiovascular disease in people with diabetes. The Company has developed a clinical laboratory test that identifies diabetic patients with the
haptoglobin genotype Hp2-2. The genetic or protein form of this test can be used to identify diabetic patients at high risk for cardiovascular complications. ...
Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
... damage subsequent to a myocardial infarction. The Company is
developing a clinical diagnostic test, based on cardiovascular risk
assessment, using
haptoglobin characterization, to identify patients at
high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...
Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
... damage subsequent to a myocardial infarction. The Company is
developing a clinical diagnostic test, based on cardiovascular risk
assessment, using
haptoglobin characterization, to identify patients at
high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...
Haptoglobin in Medical Dictionary
Haptoglobin
...
haptoglobin Definition: This is a test that measures the amount of
haptoglobin , a protein that binds free hemoglobin , in blood .
haptoglobin A protein in blood plasma that binds ...
Hantavirus
... syndrome Causes, incidence , and risk factors: Text Continued Below ... Hantavirus Hantavirus Pulmonary Syndrome ( Hantavirus )
haptoglobin Hard Liquor Consumption ( Alcohol Use ) Hardening of the Arteries ( Atherosclerosis ) ... hantavirus pulmonary syndrome (HPS) Acute ...
LDH
... released into the blood stream in increased concentration when the heart muscle becomes damaged. Examples include SGOT, CPK-MB, and LDH .
haptoglobin - The levels of this protein in the blood are low in people with hemolytic anemia . Lactate dehydrogenase ( LDH ) and bilirubin - Results of ...
Protein electrophoresis
... serum protein electrophoresis separates your blood protein s and can detect the presence of M protein s in the blood . Certain globulins (
haptoglobin s) bind with hemoglobin . Other globulins transport metals, such as iron, in the blood and help fight infection . Serum globulin can be ...
Haptoglobin in Biological Technology
Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting
... our
clinical laboratory test which determines
haptoglobin genotype may be
useful in selecting and guiding ... capable of inflicting oxidative tissue damage.
haptoglobin binds to
this extracellular hemoglobin and ... by the liver or specialized white blood cells.
haptoglobin in humans exists as three different proteins that ...
Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association
... Data Presented at the Meeting Report the Use of
haptoglobin Typing
to Predict Cardiovascular Risk, and ... Orleans, that a
new clinical test to determine
haptoglobin (Hp) genotype utilizing
intellectual property ... patients with Hp2-2 Diabetes."
At present, the
haptoglobin genotype test is offered by ARUP
Laboratories. A ...
Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
... our first commercialization
program for our
haptoglobin diagnostic," said Noah Berkowitz, M.D., ... University.
About Haptoglobin
The polymorphic
haptoglobin (Hp) protein is derived from two alleles, 1
and ... it has been established that the
haptoglobin genotype is an
independent risk factor for ...
Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
... Cardiovascular Events in Diabetics with
haptoglobin 2-2 Genotype
... who tested positive for a genetic
marker called
haptoglobin 2-2 (Hp2-2). This sub-analysis was published ... is developing a
diagnostic product to identify
haptoglobin types. "This study demonstrates
that positive ...
Synvista Therapeutics Posts Letter to Stockholders on Web Site
... on which we are building our business. We have:
-- Advanced our
haptoglobin (Hp) diagnostic test. -- Developed a test for Carboxy-methyl-lysine ... 21, demonstrated that
in patients with Diabetes Mellitus (DM) who had the
haptoglobin 2-2 (Hp2-2)
genotype, supplementation with Vitamin E therapy decreased ...
Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
... held November 10th - 12th at the New
York Palace Hotel in New York City.
Dr. Berkowitz will discuss the company's planned commercialization of
its
haptoglobin test kit for diabetes and ongoing Phase 2 initiatives for
alagebrium in heart failure. He will also provide an update of recent
milestones.
The ...
Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
... for SYI-2074 (formerly ALT-2074) in cardiovascular diseases,
alagebrium in heart failure and diabetic nephropathy and progress on the
company's
haptoglobin diagnostic test. He will also provide an update of
recent milestones and executive appointments.
The presentation will be simultaneously webcast ...
Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
... damage subsequent to a myocardial infarction. The Company is
developing a clinical diagnostic test, based on cardiovascular risk
assessment using
haptoglobin characterization, to identify patients at high
risk for cardiovascular complications of diabetes.
Synvista Therapeutics also is developing ...
Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
... damage subsequent to a myocardial infarction. The Company is
developing a clinical diagnostic test, based on cardiovascular risk
assessment using
haptoglobin characterization, to identify patients at high
risk for cardiovascular complications of diabetes.
Synvista Therapeutics also is developing ...
Synvista Therapeutics to be Featured on Wallst.net
... damage subsequent to a myocardial infarction. The Company is
developing a clinical diagnostic test, based on cardiovascular risk
assessment, using
haptoglobin characterization, to identify patients at
high risk for cardiovascular complications of diabetes. Synvista Therapeutics also is developing ...
Haptoglobin in Biological Products
Goat Anti-Human Haptoglobin Polyclonal Antibody, Unconjugated from Abcam
Description:... Goat polyclonal to
haptoglobin ( Abpromise for all tested applications). Antigen: Affinity purified human haptoglobin. Entrez GeneID: 3240 Swiss Protein ID: ...
Company:Abcam
Multiple Affinity Removal System from Agilent Technologies
Description:... one device. With this revolutionary system, you can: Remove six targeted, high-abundant proteins: albumin, lgG, antitrypsin, lgA, transferrin and
haptoglobin (representing 85-90% of total serum protein mass) Improve the results you get with protein separation methods such as 1DGE, 2DGE and MD-HPLC Go ...
Company:Agilent Technologies